A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Status:
Completed

Trial end date:
2004-09-01

Target enrollment:

Participant gender:

The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.

Phase 2

University of Chicago

Cisplatin
Fluorouracil
Hydroxyurea
Lenograstim